Cargando…

Effective Intravitreal Injections of Bevacizumab in a Case of Serous Macular Detachment from the Superior Border of the Posterior Staphyloma

PURPOSE: We present an atypical case of submacular fluid leading to serous macular detachment. METHOD/PATIENT: A 69-year-old man was evaluated for metamorphopsia in the left eye. RESULTS: Best-corrected visual acuity was 20/25 in both eyes. He had undergone cataract surgeries in both eyes 12 years a...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsubota, Yukiko, Takahashi, Hidenori, Sugisaki, Kenji, Tanabe, Tatsuro, Fujino, Yujiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5301098/
https://www.ncbi.nlm.nih.gov/pubmed/28203196
http://dx.doi.org/10.1159/000453605
_version_ 1782506299599093760
author Tsubota, Yukiko
Takahashi, Hidenori
Sugisaki, Kenji
Tanabe, Tatsuro
Fujino, Yujiro
author_facet Tsubota, Yukiko
Takahashi, Hidenori
Sugisaki, Kenji
Tanabe, Tatsuro
Fujino, Yujiro
author_sort Tsubota, Yukiko
collection PubMed
description PURPOSE: We present an atypical case of submacular fluid leading to serous macular detachment. METHOD/PATIENT: A 69-year-old man was evaluated for metamorphopsia in the left eye. RESULTS: Best-corrected visual acuity was 20/25 in both eyes. He had undergone cataract surgeries in both eyes 12 years ago. The axial length was 25.93 mm (OD) and 24.12 mm (OS). Optical coherence tomography showed posterior staphylomas and subretinal fluid on the superior border of the staphylomas in both eyes; in the left eye, submacular fluid was noted extending up to the macula. Fundus fluorescein angiography revealed leakage from the superior border of the staphylomas in both eyes. The fluid persisted for 4 months. Four consecutive, monthly injections of bevacizumab (1.25 mg/0.05 mL) were administered in the left eye; subsequently, the subretinal fluid gradually dissipated from the macula and became localized at the superior border of the staphyloma. This localization persisted for 12 months. CONCLUSIONS: We have detailed a case of submacular fluid that spread from the superior border of the posterior staphyloma in a patient with macular detachment, in whom intravitreal injections of bevacizumab were highly effective in eliminating the fluid.
format Online
Article
Text
id pubmed-5301098
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-53010982017-02-15 Effective Intravitreal Injections of Bevacizumab in a Case of Serous Macular Detachment from the Superior Border of the Posterior Staphyloma Tsubota, Yukiko Takahashi, Hidenori Sugisaki, Kenji Tanabe, Tatsuro Fujino, Yujiro Case Rep Ophthalmol Case Report PURPOSE: We present an atypical case of submacular fluid leading to serous macular detachment. METHOD/PATIENT: A 69-year-old man was evaluated for metamorphopsia in the left eye. RESULTS: Best-corrected visual acuity was 20/25 in both eyes. He had undergone cataract surgeries in both eyes 12 years ago. The axial length was 25.93 mm (OD) and 24.12 mm (OS). Optical coherence tomography showed posterior staphylomas and subretinal fluid on the superior border of the staphylomas in both eyes; in the left eye, submacular fluid was noted extending up to the macula. Fundus fluorescein angiography revealed leakage from the superior border of the staphylomas in both eyes. The fluid persisted for 4 months. Four consecutive, monthly injections of bevacizumab (1.25 mg/0.05 mL) were administered in the left eye; subsequently, the subretinal fluid gradually dissipated from the macula and became localized at the superior border of the staphyloma. This localization persisted for 12 months. CONCLUSIONS: We have detailed a case of submacular fluid that spread from the superior border of the posterior staphyloma in a patient with macular detachment, in whom intravitreal injections of bevacizumab were highly effective in eliminating the fluid. S. Karger AG 2017-01-26 /pmc/articles/PMC5301098/ /pubmed/28203196 http://dx.doi.org/10.1159/000453605 Text en Copyright © 2017 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc/4.0/ This article is licensed under the Creative Commons Attribution-NonCommercial-4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.
spellingShingle Case Report
Tsubota, Yukiko
Takahashi, Hidenori
Sugisaki, Kenji
Tanabe, Tatsuro
Fujino, Yujiro
Effective Intravitreal Injections of Bevacizumab in a Case of Serous Macular Detachment from the Superior Border of the Posterior Staphyloma
title Effective Intravitreal Injections of Bevacizumab in a Case of Serous Macular Detachment from the Superior Border of the Posterior Staphyloma
title_full Effective Intravitreal Injections of Bevacizumab in a Case of Serous Macular Detachment from the Superior Border of the Posterior Staphyloma
title_fullStr Effective Intravitreal Injections of Bevacizumab in a Case of Serous Macular Detachment from the Superior Border of the Posterior Staphyloma
title_full_unstemmed Effective Intravitreal Injections of Bevacizumab in a Case of Serous Macular Detachment from the Superior Border of the Posterior Staphyloma
title_short Effective Intravitreal Injections of Bevacizumab in a Case of Serous Macular Detachment from the Superior Border of the Posterior Staphyloma
title_sort effective intravitreal injections of bevacizumab in a case of serous macular detachment from the superior border of the posterior staphyloma
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5301098/
https://www.ncbi.nlm.nih.gov/pubmed/28203196
http://dx.doi.org/10.1159/000453605
work_keys_str_mv AT tsubotayukiko effectiveintravitrealinjectionsofbevacizumabinacaseofserousmaculardetachmentfromthesuperiorborderoftheposteriorstaphyloma
AT takahashihidenori effectiveintravitrealinjectionsofbevacizumabinacaseofserousmaculardetachmentfromthesuperiorborderoftheposteriorstaphyloma
AT sugisakikenji effectiveintravitrealinjectionsofbevacizumabinacaseofserousmaculardetachmentfromthesuperiorborderoftheposteriorstaphyloma
AT tanabetatsuro effectiveintravitrealinjectionsofbevacizumabinacaseofserousmaculardetachmentfromthesuperiorborderoftheposteriorstaphyloma
AT fujinoyujiro effectiveintravitrealinjectionsofbevacizumabinacaseofserousmaculardetachmentfromthesuperiorborderoftheposteriorstaphyloma